Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial.

Source:http://linkedlifedata.com/resource/pubmed/id/21448165

Br. J. Cancer 2011 Apr 12 104 8 1256-61

Download in:

View as

General Info

PMID
21448165